Publicaciones (118) Publicaciones de EMILIO PEREZ TRALLERO

2021

  1. Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study

    PLoS ONE, Vol. 16, Núm. 11 November

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  4. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Clarithromycin resistance in Helicobacter pylori and its molecular determinants in Northern Spain, 2013–2015

    Journal of Global Antimicrobial Resistance, Vol. 9, pp. 43-46

  2. Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

    PLoS ONE, Vol. 12, Núm. 4

  3. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  4. Erratum to “IV Spanish Consensus Conference on Helicobacter pylori infection treatment” <(Gastroenterol Hepatol (2016) 39 (697–721)> (Gastroenterologia y Hepatologia (S0210570516300589) (10.1016/j.gastrohep.2016.05.003))

    Gastroenterologia y Hepatologia

  5. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  6. How long until routine Helicobacter pylori antimicrobial susceptibility testing?

    The Lancet Infectious Diseases

  7. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

  8. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study

    Vaccine, Vol. 35, Núm. 39, pp. 5264-5270

  9. Thirty years of human infections caused by Yersinia enterocolitica in northern Spain: 1985-2014

    Epidemiology and Infection, Vol. 145, Núm. 11, pp. 2197-2203

2016

  1. Nocardia donostiensis sp. nov., isolated from human respiratory specimens

    Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology, Vol. 109, Núm. 5, pp. 653-660

  2. Autochthonous Nocardia cerradoensis infection in humans, Spain, 2011 and 2014

    Emerging Infectious Diseases, Vol. 22, Núm. 1, pp. 109-111

  3. Biomarker tools to design clinical vaccines determined from a study of annual listeriosis incidence in northern Spain

    Frontiers in Immunology, Vol. 7, Núm. NOV

  4. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

  5. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori

    Gastroenterologia y Hepatologia

  6. Long-term epidemiology of streptococcus pneumoniae serogroup 6 in a region of southern Europe with special reference to serotype 6E

    PLoS ONE, Vol. 11, Núm. 2